<DOC>
	<DOCNO>NCT00234910</DOCNO>
	<brief_summary>The purpose study obtain preliminary assessment antiviral activity tolerability simplify Kaletra dual agent therapy initial treatment HIV infection , relative Kaletra three drug standard care reference arm .</brief_summary>
	<brief_title>Efficacy Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard Care Regimen Treatment naïve HIV Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>HIV positive &gt; 18 year age HIV RNA &gt; 400 copies/mL Any CD 4 cell count Antiretroviral naïve No acute illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Lopinavir</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Kaletra</keyword>
	<keyword>Tenofovir</keyword>
	<keyword>HIV infection</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>